Skip to content
value.today

Abbott Laboratories vs Intersect Ent

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Abbott Laboratories is the larger company by market value: $181.1 B against $914 M for Intersect Ent, 198 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 7, 2022 for Intersect Ent). Intersect Ent's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
  • Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $107 M for Intersect Ent in the year to December 2021.
  • Abbott Laboratories made a net profit of $6.5 B, while Intersect Ent made a net loss of $160 M.
  • Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against -149.5% for Intersect Ent.
  • Abbott Laboratories employs more people: 115,000 against 406 at Intersect Ent. Each employee brings in about $385,461 of revenue at Abbott Laboratories and $262,931 at Intersect Ent.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

039791181582020202120222023202420252026Abbott Laboratories 119Intersect Ent 117

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$11B$22B$33B$44B2013201520172019202120232025Abbott Laboratories $44BIntersect Ent $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbott Laboratories
ABT · #117 in the world
Intersect Ent
XENT
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Devices
Founded18882003
Size
Market cap$181.1 B$914 M*
Revenue$44.3 B$107 M
Net income$6.5 B▲ best$-160 M
Employees115,000406
Valuation
P/E ratio38.5×—
Price to sales3.8×—
Price to book3.5×—
Free cash flow yield4.1%—
Profitability
Gross margin56.4%—
Operating margin18.2%—
Net margin14.7%—
Return on equity13.1%—
Return on invested capital11.2%—
Growth
Revenue growth5.7%—
Revenue growth, 3 years a year0.5%—
Earnings per share growth-51.3%—
Financial strength
Debt to equity0.3×—
Cash
Free cash flow margin16.7%—
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.8%—
Strength scores
Piotroski F-score6 of 9—
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2022

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Abbott Laboratories or Intersect Ent?

Abbott Laboratories is the larger company by market value: $181.1 B against $914 M for Intersect Ent, 198 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 7, 2022 for Intersect Ent). Intersect Ent's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, Abbott Laboratories or Intersect Ent?

Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $107 M for Intersect Ent in the year to December 2021. Abbott Laboratories made a net profit of $6.5 B, while Intersect Ent made a net loss of $160 M.

Which is more profitable, Abbott Laboratories or Intersect Ent?

Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against -149.5% for Intersect Ent.

Which has more employees, Abbott Laboratories or Intersect Ent?

Abbott Laboratories employs more people: 115,000 against 406 at Intersect Ent. Each employee brings in about $385,461 of revenue at Abbott Laboratories and $262,931 at Intersect Ent.

Sources#

Every figure on this page comes from these, with the date shown next to it.